As of 2025-10-15, the Relative Valuation of Harmony Biosciences Holdings Inc (HRMY) is 59.04 USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.84 USD, the upside of Harmony Biosciences Holdings Inc based on Relative Valuation is 120.0%.
The range of the Relative Valuation is 35.22 - 80.90 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 23.1x | 16.6x |
| Forward P/E multiples | 19.1x - 29.5x | 24.0x |
| Fair Price | 35.22 - 80.90 | 59.04 |
| Upside | 31.2% - 201.4% | 120.0% |
| Date | P/E |
| 2025-10-14 | 8.41 |
| 2025-10-13 | 8.38 |
| 2025-10-10 | 8.44 |
| 2025-10-09 | 8.52 |
| 2025-10-08 | 8.45 |
| 2025-10-07 | 8.60 |
| 2025-10-06 | 8.46 |
| 2025-10-03 | 8.68 |
| 2025-10-02 | 8.51 |
| 2025-10-01 | 8.56 |
| 2025-09-30 | 8.76 |
| 2025-09-29 | 8.79 |
| 2025-09-26 | 8.75 |
| 2025-09-25 | 8.60 |
| 2025-09-24 | 8.51 |
| 2025-09-23 | 10.20 |
| 2025-09-22 | 10.31 |
| 2025-09-19 | 10.35 |
| 2025-09-18 | 10.38 |
| 2025-09-17 | 10.20 |
| 2025-09-16 | 10.27 |
| 2025-09-15 | 10.34 |
| 2025-09-12 | 10.30 |
| 2025-09-11 | 10.63 |
| 2025-09-10 | 10.56 |
| 2025-09-09 | 10.81 |
| 2025-09-08 | 11.39 |
| 2025-09-05 | 11.45 |
| 2025-09-04 | 11.54 |
| 2025-09-03 | 11.94 |
| 2025-09-02 | 11.80 |
| 2025-08-29 | 11.73 |
| 2025-08-28 | 12.07 |
| 2025-08-27 | 12.10 |
| 2025-08-26 | 11.82 |
| 2025-08-25 | 11.90 |
| 2025-08-22 | 12.04 |
| 2025-08-21 | 11.86 |
| 2025-08-20 | 11.65 |
| 2025-08-19 | 11.58 |
| 2025-08-18 | 11.58 |
| 2025-08-15 | 11.73 |
| 2025-08-14 | 11.61 |
| 2025-08-13 | 11.66 |
| 2025-08-12 | 11.28 |
| 2025-08-11 | 11.07 |
| 2025-08-08 | 10.87 |
| 2025-08-07 | 10.87 |
| 2025-08-06 | 11.03 |
| 2025-08-05 | 11.11 |